Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Mount Everest Climbers 'Poisoned' by Guides Prompting Mass Helicopter Rescues in $20 Million Insurance Fraud Scheme, Police Say - 2Israel halts defense sales to France, citing 'hostile attitude,' sources tell 'Post'
- 3Chicago reports first rabies-positive dog in 61 years. What we know.
- 4Viable Monetary Tips to Advance Your Monetary Circumstance
- 5Firefighters rescue two Israelis trapped in vehicles on flooded roads in West Bank
- The Way to Fruitful Weight reduction: Individual Wellbeing Excursions
- Explosions heard across Tehran after IDF announces wave of strikes on regime terror targets
- PHOTO ESSAY: Summer camp for kids with autoimmune diseases
- Manual for 6 famous sorts of cheddar
- Instructions to Help a Friend or family member Determined to have Cellular breakdown in the lungs
- German unemployment rate falls to 6.4%, but 3 million still jobless
- Instructions to Pick the Right Toothpaste for Your Dental Requirements
- 6 Top of the line Lodgings All over The Planet, Which One Do You Concur With
- Beneficial Growing Conditions in West Africa Weigh on Cocoa Prices
